Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 2,345.00
+45.00 (1.96%)
At close: Sep 18, 2026
Kookjeon Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 14,181 | 7,694 | 46,824 | 10,992 | 21,546 | 19,099 |
Short-Term Investments | - | 5,166 | - | 15,000 | 45,000 | 20,160 |
Trading Asset Securities | 18,973 | 17,689 | - | 38,840 | 28,425 | - |
Cash & Short-Term Investments | 33,155 | 30,549 | 46,824 | 64,833 | 94,971 | 39,259 |
Cash Growth | -3.25% | -34.76% | -27.78% | -31.73% | 141.91% | - |
Accounts Receivable | 29,835 | 23,291 | 28,779 | 26,850 | 21,923 | 20,015 |
Other Receivables | 101.95 | 168.7 | 66.66 | 1,964 | 867.93 | 194.62 |
Receivables | 30,367 | 23,860 | 29,255 | 29,065 | 23,403 | 20,409 |
Inventory | 19,792 | 18,026 | 26,798 | 27,563 | 20,209 | 16,207 |
Prepaid Expenses | - | 816.82 | 538.53 | 494.91 | 246.48 | 143.8 |
Other Current Assets | 2,329 | 1,495 | 1,773 | 2,036 | 4,064 | 896.09 |
Total Current Assets | 85,642 | 74,746 | 105,189 | 123,992 | 142,893 | 76,915 |
Property, Plant & Equipment | 86,248 | 85,059 | 87,360 | 86,060 | 46,118 | 24,026 |
Long-Term Investments | 4,176 | 4,335 | 5,322 | 4,364 | 3,173 | 3,493 |
Goodwill | 420.39 | 420.39 | 420.39 | 420.39 | 420.39 | - |
Other Intangible Assets | 1,068 | 903.17 | 908.17 | 971 | 903.51 | 422.37 |
Long-Term Deferred Tax Assets | 2,790 | 3,048 | 2,185 | 1,964 | - | 794.9 |
Long-Term Deferred Charges | 3,500 | 3,500 | 3,500 | - | - | - |
Other Long-Term Assets | 5,265 | 7,035 | 7,169 | 7,090 | 2,379 | 517.79 |
Total Assets | 189,200 | 179,207 | 212,273 | 225,102 | 196,097 | 106,989 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 16,497 | 11,887 | 17,833 | 11,693 | 9,474 | 10,989 |
Accrued Expenses | 334.24 | 301.7 | 359.99 | 289.73 | 178.99 | 83.02 |
Short-Term Debt | 22,137 | 27,164 | 37,461 | 15,224 | 7,883 | 5,133 |
Current Portion of Long-Term Debt | 2,479 | 2,479 | 2,918 | 36,802 | 26,015 | 1,457 |
Current Portion of Leases | 211.93 | 186.24 | 274.88 | 236.17 | 147.15 | 124.88 |
Current Income Taxes Payable | 323.17 | - | - | - | - | 1,057 |
Current Unearned Revenue | - | - | - | 35.16 | - | - |
Other Current Liabilities | 16,243 | 24,059 | 29,729 | 35,542 | 26,993 | 3,007 |
Total Current Liabilities | 58,225 | 66,076 | 88,576 | 99,823 | 70,691 | 21,852 |
Long-Term Debt | 15,272 | 15,526 | 24,035 | 26,183 | 25,091 | 942.84 |
Long-Term Leases | 537.69 | 546.79 | 622.23 | 334.14 | 202.84 | 193.97 |
Pension & Post-Retirement Benefits | - | -0 | -0 | -0 | -0 | -0 |
Long-Term Deferred Tax Liabilities | - | - | 10.45 | 10.45 | 1,365 | - |
Other Long-Term Liabilities | 1,162 | 1,185 | 1,529 | 1,296 | 6,425 | 849.76 |
Total Liabilities | 75,197 | 83,335 | 114,774 | 127,646 | 103,774 | 23,838 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5,399 | 5,018 | 4,907 | 4,907 | 4,907 | 4,907 |
Additional Paid-In Capital | 78,317 | 65,713 | 62,139 | 62,386 | 62,386 | 62,397 |
Retained Earnings | 29,033 | 25,585 | 30,375 | 29,129 | 24,305 | 15,848 |
Treasury Stock | -1.16 | -1.16 | -1.16 | -1.16 | -1.16 | -1.16 |
Comprehensive Income & Other | -0 | 0 | -0 | 0 | 0 | 0 |
Total Common Equity | 112,747 | 96,314 | 97,420 | 96,422 | 91,597 | 83,150 |
Minority Interest | 1,256 | -442.06 | 79.38 | 1,035 | 725.74 | - |
Shareholders' Equity | 114,003 | 95,872 | 97,499 | 97,456 | 92,323 | 83,150 |
Total Liabilities & Equity | 189,200 | 179,207 | 212,273 | 225,102 | 196,097 | 106,989 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 40,637 | 45,902 | 65,312 | 78,780 | 59,339 | 7,852 |
Net Cash (Debt) | -7,482 | -15,354 | -18,488 | -13,947 | 35,632 | 31,407 |
Net Cash Growth | - | - | - | - | 13.45% | - |
Net Cash Per Share | -146.21 | -307.93 | -372.69 | -284.24 | 695.44 | 712.02 |
Filing Date Shares Outstanding | 53.99 | 50.18 | 49.07 | 49.07 | 49.07 | 49.07 |
Total Common Shares Outstanding | 53.99 | 50.18 | 49.07 | 49.07 | 49.07 | 49.07 |
Working Capital | 27,418 | 8,670 | 16,613 | 24,169 | 72,202 | 55,063 |
Book Value Per Share | 2088.45 | 1919.52 | 1985.36 | 1965.01 | 1866.70 | 1694.56 |
Tangible Book Value | 111,259 | 94,991 | 96,091 | 95,030 | 90,274 | 82,728 |
Tangible Book Value Per Share | 2060.88 | 1893.14 | 1958.28 | 1936.66 | 1839.72 | 1685.95 |
Land | 21,734 | 20,724 | 20,224 | 19,837 | 15,613 | 3,997 |
Buildings | 38,993 | 38,110 | 37,374 | 36,673 | 11,300 | 8,252 |
Machinery | 33,081 | 31,886 | 30,220 | 22,297 | 11,051 | 7,554 |
Construction In Progress | - | 362.65 | 624.1 | 6,407 | 13,388 | 9,214 |